According to new modeling research, vaccinations against 10 major pathogens substantially impact public health in low-income and middle-income countries (LMICs).
Published in The Lancet on January 30, 2021, this study estimated that from 2000 to 2019, vaccinations prevented 37 million fatalities. Most of this impact is estimated to be among children younger than five years, most notably from measles vaccinations.
Vaccinations Save Lives Everywhere
HPV Vaccination Unrelated to Most Serious Adverse Events
In a nationwide cohort study, with more than 440,000 doses of human papillomavirus (HPV) vaccines administered to young women, no evidence was found to support an association between HPV vaccination and serious adverse events using both cohort analysis and self-controlled risk interval analysis.
Pregnant Women May Pass COVID-19 Antibody Protection to Infants Before Delivery
A study published by JAMA Pediatrics demonstrates maternally derived antibodies’ potential to provide neonatal protection from SARS-CoV-2 infection.
This study’s findings indicate an ‘efficient transplacental transfer of SARS-CoV-2 IgG antibodies supports the potential for maternally derived antibodies to provide neonatal protection from SARS-CoV-2 infection.’
These researchers stated on January 29, 2021, ‘Our findings align with current evidence that suggests that although placental and neonatal SARS-CoV-2 transmission may occur, such events are not common.’
EU Regulator Approves Oxford-AstraZeneca COVID-19 Vaccine
Vaccine is added to those made by Pfizer and Moderna, which have already been approved in the EU
COVID-19 Admissions, Fatalities Up for Pregnant Women
COVID-19 hospitalization rates 3.5-fold higher, case fatality rates 13.6-fold higher in pregnant patients versus similarly aged adults
New COVID-19 Variants May Weaken Efficacy of Vaccines
But experts stress that even a weakened vaccine can still largely protect people from a severe case of COVID-19
Nearly Half of U.S. Adults Want the COVID-19 Vaccine as Soon as Possible
Messages about effectiveness of the vaccine and the experience of friends and family are most influential factors
J&J COVID-19 Vaccine 66 Percent Effective in Interim Analysis
Efficacy varies by region, with 57 percent efficacy in South Africa and 72 percent efficacy in the United States
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 25 to 29, 2021. This …
Patients With RA Have Increased Anxiety During Pandemic
Anxiety during pandemic correlated with Health Assessment Questionnaire, biologic drug use, and previous anxiety point